Potential Benefits of Using a Multicomponent Vaccine for Prevention of Serogroup B Meningococcal Disease
International Journal of Infectious Diseases - Netherlands
doi 10.1016/j.ijid.2019.05.019
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2019
Authors
Publisher
Elsevier BV